Dulaglutide, 923950-08-7

Aliasulaglutide - tshuaj hauv PBS / dulaglutide

CAS Nr .: 923950-08-7

Lub tuam txhab No.: GT-F002

Sequence: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile- Ala-Trp-Leu-Val-Lys-Gly-Gl y-Gly-OH

Cov mis mos molecular: C149H221N37O49

Molecular Luj: 3314.62

Dulaglutide CAS NO.923950-08-7.jpg ib

Technical ntsuas:

Pom Dawb hmoov
purity (HPLC) yog ≥95.0%

Ib qho heterozygosity tsawg dua 2.0%

Cov ntsiab lus acetic acid nyob ntawm 5.0% mus rau 12.0%

Cov dej noo yog ≤10.0%

Cov ntsiab lus peptide yog ≥80.0%

Packing thiab Shipping:

Tsis tshua muaj kub, lub tshuab nqus tsev ntim, raug rau milligram raws li kev thov.

Product Description:

Durraglutide yog ib tug tshiab ntev-acting GLP-1R agonist, uas yog muab los ntawm fusion ntawm ob DPP-4 inhibitory GLP-1 analogues thiab tib neeg immunoglobulin hnyav saw IgG4-Fc fragment.Nws cov haujlwm zoo ib yam li cov endogenous GLP-1 hauv kev kho mob tshwm sim, nrog rau ib nrab-lub neej ntawm 5 hnub, thiab tuaj yeem ncua lub raum tshem tawm.FDA pom zoo dulaglutide rau kev txhaj tshuaj subcutaneous nyob rau lub Cuaj Hli 2014. European Commission tau pom zoo dulaglutide rau kev txhaj tshuaj subcutaneous hauv Tebchaws Europe thaum Lub Kaum Ob Hlis 2014.

Cia: Cia qhuav ntawm -20 ℃ thiab khaws cia deb ntawm lub teeb

Lus Cim: Rau kev tshawb fawb nkaus xwb, tsis yog rau tib neeg